Muzza,
Last week I saw went to my local medical practice and saw the locum GP (with many years experience)about a skin condition. He remmbered I had spoken about Relenza last time I visited (good memory).
His comment was that "it only shortened the flu clinical signs by a day or 2 at most".
I indicated that was not my experience or that of many others and that froma risk management perspective the drug company could only provide a conservative view based on published trials.
I also indicated that tamiflu resistance was widespread, including in Australia, whereas there was negligible if any evidence of clinical resistance to Relenza worldwide.
When I returned in the afternoon he said he had prescribed his first course of Relenza to a patient with possible flu.
My experience is that Relenza can lead to rapid resolution of influenza symtoms - personal experience of a close relative (previously documented on Hot Copper). In contrast 2 weeks previously I had suffered a week of severe influenza - headaches, muscle aches & pains, fever witout taking relenza. the sickest I had been for 50 years. Obviously 1 case doesn't constitute a clinical trial.
I now carry Relenza with me whenever I travel. low cost insurance.
Do other BTA holders have similar stories?
This is a major reason why I hold BTA.
Regards
Kangaroo1
- Forums
- ASX - By Stock
- google flutrends - russia moderate
Muzza,Last week I saw went to my local medical practice and saw...
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BTA (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
MTL
MANTLE MINERALS LIMITED
Nick Poll, Executive Director
Nick Poll
Executive Director
SPONSORED BY The Market Online